
TS · NYSE
Consensus is Buy across eight analysts, with a mean target of $64. The supplied consensus has no available low or high, so target clustering and the full spread cannot be established from that dataset. The broader evidence is substantially less consistent: Fintel cites a $42.20 average and a $31.54-$53.44 range, while Public cites a $45 target from five analysts. Morgan Stanley is the most bullish named firm in the supplied evidence after raising its target to $65 from $53 and upgrading Tenaris to Equal Weight on July 15; its earlier February target was $40. The least bullish cited firm-level target is that earlier Morgan Stanley figure. Revisions are mixed, with Morgan positive and Weiss downgrading from Buy (B).
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Morgan Stanley | — | $65 | +17.9% | Jul 15, 2026 | Open the report this row came from | |
| Weiss Ratings | — | — | — | Jul 10, 2026 | Open the report this row came from | |
| Morgan Stanley | — | $40 | -27.5% | Feb 23, 2026 | Open the report this row came from |